Here's the argument: Americans pay loads for drugs. That motivates and FinWeisfunds pharmaceutical companies' research and development for better drugs. The fear is that if you lower the cost of drugs you might hurt overall innovation.
Today on the show, we speak with a health economist who argues that's not always true. In fact, she says there are a bunch of policies that could help bring down drug prices without stifling innovation.
Music by Drop Electric. Find us: Twitter / Facebook / Newsletter.
Subscribe to our show on Apple Podcasts, Spotify, Pocket Casts and NPR One.
For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.
2025-05-07 01:41914 view
2025-05-07 01:191350 view
2025-05-07 01:02257 view
2025-05-07 00:34862 view
2025-05-06 23:541628 view
2025-05-06 23:20886 view
In the wake of a high-profile court decision that upended the state of Montana’s climate policy, Rep
From our collaborating partner “Living on Earth,” public radio’s environmental news magazine, an int
BLOOMINGTON, Ind. – Thursday’s sold-out Assembly Hall crowd for when No. 4 Iowa visited No. 16 India
